Abstract
There is currently no standard salvage chemotherapy regimen in patients with relapsed/ refractory DLBCL. We have previously shown that GEM-P is an effective salvage regimen in patients with relapsed/refractory lymphoma; 10 patients in this study had DLBCL (
Br J Cancer
2005
;92
:1352
–7. | OS . | PFS . |
---|---|---|
GEM-P (n=15) | 3-y 40%(95%CI 16–63) | 1-y 27%(95%CI 8–49) |
GEM-P +R (n=24) | 3-y 65%(95%CI 40–82) | 1-y 51% (95%CI 28–69) |
GEM-P ±R (n=39) | 3-y 53.4% (95% CI 35–69) | Median 157d (95% CI 42–271) |
. | OS . | PFS . |
---|---|---|
GEM-P (n=15) | 3-y 40%(95%CI 16–63) | 1-y 27%(95%CI 8–49) |
GEM-P +R (n=24) | 3-y 65%(95%CI 40–82) | 1-y 51% (95%CI 28–69) |
GEM-P ±R (n=39) | 3-y 53.4% (95% CI 35–69) | Median 157d (95% CI 42–271) |
Author notes
Corresponding author
2005, The American Society of Hematology
2005
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal